Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS: We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS: Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K(ATP) channels was greatly reduced. CONCLUSIONS: Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“can be treated with high-dose sulfonylureas despite being insulin dependent also provide a compelling case for genetic evaluation of monogenic diabetes with therapeutic and prognostic implications ( 2 – 6 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings that neonatal diabetes is most commonly due to activating mutations in genes encoding the ATP-sensitive potassium channel subunits Kir6.2 or SUR1”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
Cross sectional stature and weight reference curves for the UK, 1990.
Freeman, J. V., Cole, T. J., Chinn, S., Jones, P. R., White, E. M., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.17 · Cited by 1,457
Stoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State
Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., & Doyle, D. A. (2003) · Science · doi:10.1126/science.1085028 · Cited by 785
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Self-citationAssociation and Stoichiometry of KATP Channel Subunits
Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., & Bryan, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80321-9 · Cited by 692
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationMutations in the glucokinase gene of the fetus result in reduced birth weight
Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., & Ellard, S. (1998) · Nature Genetics · doi:10.1038/953 · Cited by 594
Self-citation
Cited by
Items 801–900 of 1,000
Ellard, S., & Franco, E. D. (2014) · Frontiers in diabetes · doi:10.1159/000362468 · Cited by 6
Self-citationMouse models of β-cell KATP channel dysfunction
Brereton, M. F., & Ashcroft, F. M. (2013) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2013.02.001 · Cited by 6
Self-citationNeonatal Diabetes With End-Stage Nephropathy
Esmatjes, E., Jiménez, A., Díaz, G., Mora, M., Casamitjana, R., de Nanclares, G. P., Castaño, L. A., & Ricart, M. J. (2008) · Diabetes Care · doi:10.2337/dc08-0823 · Cited by 5
“In transient neonatal diabetes, the disease remits, although the patient may frequently relapse (2,3).”
BackgroundPrecision medicine in KCNJ11 permanent neonatal diabetes
Greeley, S. A. W., Letourneau, L. R., & Philipson, L. H. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30138-4 · Cited by 5
Type 2 Diabetes and Genetics, 2010: Translating Knowledge into Understanding
Walford, G. A., & Florez, J. C. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0129-1 · Cited by 6
Fraser, C. S., Rubio‐Cabezas, O., Littlechild, J. A., Ellard, S., Hattersley, A. T., & Flanagan, S. E. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0227 · Cited by 5
Self-citationMonaghan, M. C., Støy, J., Streisand, R. M., Philipson, L. H., & Cogen, F. R. (2009) · Clinical Diabetes · doi:10.2337/diaclin.27.1.25 · Cited by 5
The Importance of Making a Genetic Diagnosis of Diabetes
Singh, R., & Pearson, E. R. (2006) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(06)02009-0 · Cited by 5
Self-citationTing, W.-H., Huang, C.-Y., Lo, F., Lee, H.-C., Lin, C., Guo, W.-L., & Lee, Y. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.7.661 · Cited by 5
Sperling, M. A., WEINZIMER, S. A., & Tamborlane, W. V. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50015-6 · Cited by 5
Franks, P. W. (2012) · Diabetologia · doi:10.1007/s00125-012-2683-1 · Cited by 5
“Similarly, mutations in KCNJ11, one of the first type 2 diabetes loci to be discovered, have long been associated with permanent neonatal diabetes [14] and very recently with MODY [15].”
BackgroundOpening closed inward rectifier potassium channel doors
Stary‐Weinzinger, A., Kaiser, F., van der Heyden, M. A. G., & Bendahhou, S. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70374 · Cited by 5
“Some patients showed ketoacidosis, severe developmental delay, muscle weakness, epilepsy and mild dysmorphic features (Gloyn et al., 2004); 2 – 7).”
An, M., Akyüz, M., Çapik, Ö., Yalcin, C., Bertram, R., Karataş, E. A., Karataş, Ö. F., & Yildirim, V. (2024) · Mathematical Biosciences · doi:10.1016/j.mbs.2024.109224 · Cited by 4
“Each K (ATP) channel has four Kir6 subunits and four sulfonylurea receptor subunits (Sur1) [21,22].”
A novel mutation of KCNJ11 gene in a patient with permanent neonatal diabetes mellitus
Chang, W.-L., Huang, C.-J., Lei, T.-H., Niu, D., Chiu, C., & Jap, T. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.058 · Cited by 4
“2 subunits and four sulfonylurea subunits in an octomeric structure [4].”
BackgroundShaw, N. D., & Majzoub, J. A. (2009) · International Journal of Pediatric Endocrinology · doi:10.1155/2009/453240 · Cited by 4
Neonatal Diabetes Mellitus in China
Li, Y.-H., Yuan, T., & Yu, H. (2011) · Clinical Pediatrics · doi:10.1177/0009922811427584 · Cited by 4
Marín-García, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00012-3 · Cited by 7
Diabetes and Pancreatic Cancer: A Bidirectional Relationship Perspective
Gupta, M. K., Sarojamma, V., & Vadde, R. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_3 · Cited by 4
The insulin centennial—100 years of milestones in biochemistry
Attie, A., Tang, Q.-Q., & Bornfeldt, K. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100132 · Cited by 4
Lee, M. Y., Gloyn, A. L., Maahs, D. M., & Prahalad, P. (2023) · Case Reports in Endocrinology · doi:10.1155/2023/8825724 · Cited by 6
Self-citationGlycemic control and motor development in a patient with intermediate DEND
Oka, H., Suzuki, S., Furuya, A., Matsuo, K., Amamiya, S., Oshima, M., Oka, T., Mukai, T., Okayama, A., Araki, A., et al. (2014) · Pediatrics International · doi:10.1111/ped.12294 · Cited by 4
Influence of age on the association of GIRK4 with metabolic syndrome
Li, N., Zhang, D., Zhang, J., Guo, Y., Yan, Z.-T., Wang, H., Zhou, L., Hong, J., Wang, X., & Zufeiya, A. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011129 · Cited by 4
Not All Diabetes in Infants is Type 1: A Case Report
Arce, K. M., & Pantalone, K. M. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0171-1 · Cited by 4
“6 months of age [6, 11].”
BackgroundFamilial diabetes of adulthood: A bin of ignorance that needs to be addressed
Prudente, S., Ludovico, O., & Trischitta, V. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.10.017 · Cited by 5
Disorders of Carbohydrate Metabolism
Werny, D. M., Taplin, C. E., Bennett, J. T., & Pihoker, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00099-1 · Cited by 5
Pathophysiology and Management of Disorders of Carbohydrate Metabolism and Neonatal Diabetes
Ogilvy‐Stuart, A., & Beardsall, K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00046-5 · Cited by 6
Transcription factor 7-like 2 (TCF7L2): a culprit gene in Type 2 Diabetes Mellitus
Jan, A., Jan, H., & Ullah, N. (2021) · Diabetes Mellitus · doi:10.14341/dm12313 · Cited by 4
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00769-1 · Cited by 5
Diagnostic Criteria and Classification of Diabetes
Gospin, R., Leu, J. P., & Zonszein, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_7-2 · Cited by 6
Endocrinology research—reflecting on the past decade and looking to the next
Herold, K. C., Majzoub, J. A., Melmed, S. K., Pendergrass, M., & Schlumberger, M. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.164 · Cited by 4
John, H., Flanagan, S. E., Corrall, R. J. M., Hattersley, A. T., Ellard, S., & Shepherd, M. H. (2005) · Practical Diabetes · doi:10.1002/pdi.867 · Cited by 4
Self-citationGlibenclamide controls ketosis‐prone diabetes in a 38‐year‐old woman with Kir6.2 mutation
Jose, B., Griffiths, U., PhD, T. B., Hattersley, A. T., & Milles, J. J. (2009) · Practical Diabetes · doi:10.1002/pdi.1385 · Cited by 4
Self-citationCanaux potassiques, maladies héréditaires et acquises
Mazzuca, M., & Lesage, F. (2007) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2007.04.002 · Cited by 4
van de Bunt, M., & Gloyn, A. L. (2007) · Personalized Medicine · doi:10.2217/17410541.4.3.247 · Cited by 5
Self-citationTreatment of Hyperglycemia in a 7-Year-Old Child Diagnosed With Neonatal Diabetes
Hathout, E. H., Mace, J., Bell, G. I., & Njølstad, P. R. (2006) · Diabetes Care · doi:10.2337/dc06-0487 · Cited by 4
Self-citationAspects cliniques et diagnostiques du diabète de l'enfant
Bouhours‐Nouet, N., & Coutant, R. (2011) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(11)72493-0 · Cited by 7
Lo, F. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.01.002 · Cited by 4
Biosynthesis, Processing, and Secretion of the Islet Hormones
Steiner, D. F., Rhodes, C. J., Philipson, L. H., Bell, G. I., & Chan, S. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00032-0 · Cited by 4
Genetics of Diabetes and Diabetic Complications
Prasad, R. B., Ahlqvist, E., & Groop, L. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_6 · Cited by 6
Dąbrowska‐Żamojcin, E., Tarnowski, M., Szydłowski, M., Romanowski, M., Dziedziejko, V., Safranow, K., Domański, L., & Pawlik, A. (2017) · Folia Biologica · doi:10.14712/fb2017063030115 · Cited by 4
“2) (Gloyn et al., 2004).”
Receptor, Transporter and Ion Channel Diseases
Gargus, J. J. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400158 · Cited by 4
Open to Control — New Hope for Patients with Neonatal Diabetes
Gribble, F. M., & Reimann, F. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048044 · Cited by 4
Zhu, B. J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1753393 · Cited by 3
Emel'yanov, A. O., Kuraeva, T. L., Prokofiev, S. A., Medvedeva, E. D., & Peterkova, V. A. (2014) · Problems of Endocrinology · doi:10.14341/probl201460157-63 · Cited by 3
Rhaiem, I. B., Beltrand, J., Vermillac, G., Kariyawasam, D., Geraud, D., Besançon, A., Godot, C., Berdugo, M., Bonnard, A. A., Cavé, H., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf083 · Cited by 3
“The cause is usually an activating mutation in KCNJ11 or ABCC8 and less often an abnormality at the 6q24 locus [1-3].”
Nagano, N., Urakami, T., Mine, Y., Watanabe, H., Yoshida, A., Suzuki, J., Saito, H., Ishige, M., Takahashi, S., Mugishima, H., et al. (2012) · Pediatrics International · doi:10.1111/j.1442-200x.2011.03413.x · Cited by 3
McCormack, S. E., & Grant, S. F. A. (2015) · Diabetes · doi:10.2337/db14-1836 · Cited by 3
“For example, KCNJ11 encodes an ATPsensitive K channel that couples glucose-stimulated energy production to insulin secretion in the b-cell; mutations in KCNJ11 have been associated with neonatal diabetes (7).”
BackgroundKavvoura, F. K., & Owen, K. R. (2014) · Medicine · doi:10.1016/j.mpmed.2014.09.009 · Cited by 4
Ion Channels and Regulation of Insulin Secretion in Beta-Cells
Oluwamodupe, C., & Babalola, O. O. (2024) · Current Molecular Biology Reports · doi:10.1007/s40610-024-00162-z · Cited by 6
“Recent studies indicate that a specific type of cation-selec-tive channel, known as transient receptor potential channels, plays a role in contributing to the background inward current in beta cells [40, 48].”
Letter re: Neonatal Diabetes Mellitus and Mutation in the HNF-1β Gene
D’Amato, E., & Lorini, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1156 · Cited by 3
Monogenic Diabetes Mellitus: Neonatal Diabetes and Maturity-Onset Diabetes of the Young
Greeley, S. A. W., McCauley, M. K., Philipson, L. H., & Sperling, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00010-5 · Cited by 3
Barash, G., Bassan, H., Livne, A., Benyamini, L., Heyman, E., Bowman, P., & Rachmiel, M. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01763-1 · Cited by 3
Poon, S. W.-Y., Chung, B. H., Tsang, M. H., & Tung, J. Y. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0013 · Cited by 3
“Thus, beta cells remain hyperpolarized even in the presence of glucose, thereby reducing electrical activity and insulin release (3).”
BackgroundA synonymous KCNJ11 variant leading to MODY13: A case report and literature review
Chen, C., Piao, Y., & Sang, Y. (2023) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2023.101043 · Cited by 3
“Mutations in KCNJ11 are pathogenic in TNDM3 (Diabetes Mellitus, Transient Neonatal, 3, OMIM#610582), PNDM2 (Diabetes Mellitus, Permanent Neonatal, 2, OMIM#618856), HHF2 (Hyperinsulinemic Hypoglycemia, Familial, 2, OMIM#601820), type 2 diabetes, and MODY13 [9,12 – 15].”
BackgroundManagement of Neonatal and Infancy-Onset Diabetes Mellitus
Sövik, O., Tanšek, M. Ž., Sagen, J. V., & Njølstad, P. R. (2007) · Endocrine development · doi:10.1159/000111062 · Cited by 3
Self-citationNieves-Rivera, F., & de Pijem, L. G. (2011) · PubMed · Cited by 3
Fremskritt innen diabetesgenetikk
Njølstad, P. R., Hertel, J. K., Sövik, O., Ræder, H., Johansson, S., & Molven, A. (2010) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.09.1035 · Cited by 6
Self-citationClinique et diagnostic du diabète de l'enfant
Bouhours‐Nouet, N., & Coutant, R. (2005) · EMC - Pédiatrie · doi:10.1016/j.emcped.2005.06.001 · Cited by 11
Rachmiel, M., Rubio‐Cabezas, O., Ellard, S., Hattersley, A. T., & Perlman, K. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00809.x · Cited by 3
“2 (4) and SUR1 (5, 6) or heterozygous mutations in the”
BackgroundSelf-citationType 2 Diabetes: Genetic Advance and Aetiology
Dehwah, M. A. S., Shuang, Z., Hua, W. Z., Min, W., & Huang, Q. (2009) · Journal of Applied Sciences · doi:10.3923/jas.2009.3407.3423 · Cited by 3
How will genetic approaches assist in the management of respiratory diseases?
Hall, I. P. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.03.003 · Cited by 3
Water intake disorder in a DEND syndrome afflicted patient with R50P mutation
Maejima, Y., Hasegawa, S., Horita, S., Kumamoto, K., Galvanovskis, J., Takenoshita, S., & Shimomura, K. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej14-0392 · Cited by 3
Finding Inward Rectifier Channel Inhibitors: Why and How?
van der Heyden, M. A. G. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00095 · Cited by 3
What type of diabetes do young people have?
Pihoker, C. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0020-0 · Cited by 4
“PND is associated with mutations to the recently described gene KCNJ11, which encodes the ATP-sensitive potassium channel subunit Kir6.2, and with mutations in the genes encoding the transcription factor insulin promoter factor-1, eukaryotic translation initiation factor-2a kinase 3, glucokinase, or forkhead box-P3 [3…”
BackgroundMohamed, I. M. T. N. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000332 · Cited by 3
“Permanent neonatal diabetes mellitus (PNDM) /monogenic diabetes of infancy (MDI) is a rare condition associated with defects in genes that play major roles in pancreatic beta cell development and function; mutations in the genes encoding the ATP-sensitive potassium channel (K-ATP) subunits, KCNJ11 (encoding KIR 6.2 su…”
BackgroundInfluentialFlorez, J. C., Udler, M. S., & Hanson, R. L. (2021) · Europe PMC (PubMed Central) · Cited by 6
Ahmed, D. M. F., Dayem, S. M. E., Kader, M. A., Khalifa, R. H., El-Lebedy, D. H., Kamel, S. A., & Shawky, S. (2016) · Laboratory Medicine · doi:10.1093/labmed/lmw067 · Cited by 3
Madani, H. A., Elkaffas, R. H., AlKholy, B. M., Musa, N., Shaalan, Y. M., El-Kaffas, R., Hassan, M. M., Hafez, M. M., Flanagan, S. E., Franco, E. D., et al. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0658-6 · Cited by 3
“channels could cause developmental delay, muscle weakness, and epilepsy [19].”
BackgroundAghelan, Z., Kiani, S., Nasiri, A., Sadeghi, M., Farrokhi, A., & Khodarahmi, R. (2020) · PubMed Central · doi:10.22088/ijmcm.bums.9.2.107 · Cited by 4
“Accordingly, plasma membrane of β cells is continuously hyperpolarized, and glucosedependent insulin secretion does not occur (21).”
BackgroundDiabetes in Children and Adolescents
Rossi, M. A., & Yosypiv, I. V. (2022) · Springer eBooks · doi:10.1007/978-3-030-86020-2_7 · Cited by 3
Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children and Adolescents
Holder, M., Kapellen, T. M., Ziegler, R., Bürger-Büsing, J., Danne, T., Dost, A., Holl, R. W., Holterhus, P., Karges, B., Kordonouri, O., et al. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1624-3388 · Cited by 6
FARMACOGENÉTICA DO TRATAMENTO DE DIABETE MELITO
Hirata, R., & Hirata, M. (2006) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v39i4p554-561 · Cited by 3
Neonatal Diabetes in a Singapore Children’s Hospital: Molecular Diagnoses of Four Cases
Vasanwala, R. F., Lim, S. H., Ellard, S., & Yap, F. K. P. (2014) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v43n6p314 · Cited by 3
Self-citationSun, F., Du, W., Ma, J., Gu, M., Wang, J., Zhu, H., Song, H., & Gao, G.-Q. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0603-3463 · Cited by 4
“2 and SUR1 subunits, respectively, of the KATP channel [10, 13, 14].”
BackgroundThe Role of Pharmacogenomics in Diabetes
Lam, Y. W. F., Duggirala, R., Jenkinson, C. P., & Arya, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812626-4.00009-7 · Cited by 4
Genetic Risk Factors for Type 2 Diabetes and Related Traits
Hertel, J. K. (2012) · NVA (Nasjonalt vitenarkiv) · Cited by 3
Paediatric diabetes — which children can gain insulin independence?
Srinivasan, S., & Donaghue, K. C. (2007) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb00991.x · Cited by 3
Self-citationBest Practice & Research Clinical Endocrinology & Metabolism
Robinson, K. A., Krüger, P., Prins, J. B., Venkatesh, B., & Care, I. (2011) · Cited by 3
Exocrine or endocrine? A circulating pancreatic elastase that regulates glucose homeostasis
Gloyn, A. L. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0107-y · Cited by 3
Self-citationNorris, A. W., & Wolfsdorf, J. I. (2005) · Wiley eBooks · doi:10.1002/9780470987117.ch21 · Cited by 15
Polak, M., Galdérisi, A., Busiah, K., Vaivre‐Douret, L., Bonnard, A. A., Berdugo, M., Kermorvant‐Duchemin, E., Cavé, H., & Beltrand, J. (2024) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2024.04.026 · Cited by 2
Bayliss–Starling Prize Lecture: KATP channel pathophysiology – a whole‐body odyssey
Nichols, C. G. (2025) · The Journal of Physiology · doi:10.1113/jp287415 · Cited by 2
“2 (Gloyn et al., 2004), and SUR1 (Babenko et al., 2006), are the major cause of human neonatal diabetes mellitus (NDM, MIM no. 606176) led quickly to the recognition that treatment with sulfonylurea inhibitors can be an essentially magic-bullet treatment, stimulating physiological secretion of…”
El-Deyarbi, M., Ahmed, L. A., King, J., Adi, Z. S., Juboori, A. A., Mansour, N. A., Nuaimi, H. A., Beiram, R., & Aburuz, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327211 · Cited by 4
“…K intake is a cause of hypokalaemia in these patients [31], and it is reportedly associated with the development of hyperglycaemia by disrupting the function of ATP-sensitive K channels in pancreatic islets, leading to impairment of K-dependent insulin release in response to glucose overload [32].”
Monoacylglycerol as a Metabolic Coupling Factor in Glucose-Stimulated Insulin Secretion
Zhao, S., Iglesias, J., Mugabo, Y., Peyot, M., Joly, E. C., Madiraju, S. R. M., & Prentki, M. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.019 · Cited by 2
“Additional studies predict that the incidence of T1D may be increasing at a rate of 3 - 4% a year (Dahlquist, 1998; Gloyn et al., 2004).”
BackgroundPhysiological and clinical role of insulin in the neonate
Beardsall, K., Acerini, C. L., & Dunger, D. B. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.58 · Cited by 2
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01048-x · Cited by 2
The Role of Pharmacogenomics in Diabetes, HIV Infection, and Pain Management
Aquilante, C. L., & Lam, Y. W. F. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-391918-2.00007-x · Cited by 2
Zübarioğlu, A. U., Bülbül, A., & Uslu, H. S. (2018) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2017.51422 · Cited by 3
“2 subunits, are responsible from approximately half of the cases.[21-23] These cases are diagnosed within the first 2 months of age.”
BackgroundCao, L., He, Y., Huang, Q., Zhang, Y., Deng, P., Du, W., Hua, Z., Zhu, M., & Wei, H. (2020) · Endocrine · doi:10.1007/s12020-020-02279-4 · Cited by 2
(2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0755-7.00583-2 · Cited by 2
Diagnostic Criteria and Classification of Diabetes
Gospin, R., & Zonszein, J. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_7-1 · Cited by 2
Classification of Neonatal Diabetes
Franco, E. D., & Johnson, M. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-07008-2_4 · Cited by 2
Evin, F., Işık, E., Önay, H., Özen, S., Darcan, Ş., & Gökşen, D. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0642 · Cited by 2
Naz, F., Qadir, R., Baammi, S., Ali, A., & Rehman, M. U. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15336-5.00012-9 · Cited by 2
Inwardly rectifying potassium channels (KIR) in GtoPdb v.2023.1
Adelman, J. P., Clapham, D. E., Hibino, H., Inanobe, A., Jan, L. Y., Karschin, A., Kubo, Y., Kurachi, Y., Lazdunski, M., Miki, T., et al. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f74/2023.1 · Cited by 3
Advancements in pharmacotherapy options for treating diabetes in children and adolescents
Daniali, M., Nikfar, S., & Abdollahi, M. R. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2290491 · Cited by 3
“However, these studies also reported some limitations and challenges of using sulfonylurea in neonatal diabetes, such as severe hyperglycemia after missing a single dose [29] or asymptomatic hypoglycemia [30].”
BackgroundDiabetes in Children and Adolescents
Šumník, Z., & Průhová, Š. (2024) · Endocrinology · doi:10.1007/978-3-030-23709-7_10 · Cited by 2
Identification of Mutations in the Kir6.2 Subunit of the KATP Channel
Flanagan, S. E., & Ellard, S. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-526-8_18 · Cited by 2
Self-citationFrom Bacteria to Human: Biophysical Studies of Inward Rectifying Potassium Channels
Cheng, W. W.-L. (2012) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7gx48kb · Cited by 2
Traitement du diabète de l'enfant et de l'adolescent
Boileau, P., Merle, B., & Bougneres, P. F. (2005) · EMC - Pédiatrie · doi:10.1016/j.emcped.2005.01.001 · Cited by 5
Metadata
- Authors
- Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., Edghill, E. L., Frayling, T. M., Temple, I. K., Mackay, D., Shield, J. P. H., Sumnik, Z., van Rhijn, A., Wales, J. K. H., Clark, P., Gorman, S., Aisenberg, J., Ellard, S., Njølstad, P. R., Ashcroft, F. M., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- University of Oxford (GB)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Children's Hospital at Westmead (AU)
- University of Bergen (NO)
- National Health Service (GB)
- Salisbury District Hospital (GB)
- Sheffield Children's Hospital (GB)
- St. Luke's Hospital (GB)
- Hackensack University Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-29
- Volume
- 350
- Issue
- 18
- Pages
- 1838-1849
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012515461
- Cited by
- 1,137
- References
- 38
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 31 · 2023: 44 · 2022: 37 · 2021: 49 · 2020: 33 · 2019: 50 · 2018: 57 · 2017: 51 · 2016: 55 · 2015: 49 · 2014: 60 · 2013: 55 · 2012: 45
- FWCI
- 70.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- permanent neonatal diabetes, Kir6.2, KCNJ11, ATP-sensitive potassium channels, activating mutations, missense mutations, SUR1, tolbutamide, glucose-stimulated insulin secretion, developmental delay, muscle weakness, epilepsy, genetic diagnosis
- MeSH terms
- Developmental Disabilities, Diabetes Mellitus, DNA Mutational Analysis, Epilepsy, Face, Female, Heterozygote, Humans, Infant, Newborn, Islets of Langerhans, Male, Mutation, Pedigree, Sequence Analysis, DNA, Potassium Channels, Inwardly Rectifying
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.